Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Immunogenet ; 45(3): 118-127, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29675993

ABSTRACT

Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) are components of the lectin pathway, which activate the complement system after binding to the HCV structural proteins E1 and E2. We haplotyped 11 MASP2 polymorphisms in 103 HCV patients and 205 controls and measured MASP-2 levels in 67 HCV patients and 77 controls to better understand the role of MASP-2 in hepatitis C susceptibility and disease severity according to viral genotype and fibrosis levels. The haplotype block MASP2*ARDP was associated with protection against HCV infection (OR = 0.49, p = .044) and lower MASP-2 levels in controls (p = .021), while haplotype block AGTDVRC was significantly increased in patients (OR = 7.58, p = .003). MASP-2 levels were lower in patients than in controls (p < .001) and in patients with viral genotype 1 or 4 (poor responders to treatment) than genotype 3 (p = .022) and correlated inversely with the levels of alkaline phosphatase, especially in individuals with fibrosis 3 or 4 (R = -.7, p = .005). MASP2 gene polymorphisms modulate basal gene expression, which may influence the quality of complement response against HCV. MASP-2 levels decrease during chronic disease, independently of MASP2 genotypes, most probably due to consumption and attenuation mechanisms of viral origin and by the reduced liver function, the site of MASP-2 production.


Subject(s)
Haplotypes , Hepacivirus , Hepatitis C/genetics , Hepatitis C/metabolism , Mannose-Binding Protein-Associated Serine Proteases/genetics , Mannose-Binding Protein-Associated Serine Proteases/metabolism , Adult , Aged , Aged, 80 and over , Biomarkers , Case-Control Studies , Exons , Female , Genetic Predisposition to Disease , Genotype , Hepacivirus/genetics , Hepatitis C/diagnosis , Hepatitis C/virology , Humans , Introns , Male , Middle Aged , Polymorphism, Single Nucleotide , Promoter Regions, Genetic , Severity of Illness Index , Young Adult
2.
Mol Immunol ; 67(1): 85-100, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25862418

ABSTRACT

The lectin pathway of the complement system has a pivotal role in the defense against infectious organisms. After binding of mannan-binding lectin (MBL), ficolins or collectin 11 to carbohydrates or acetylated residues on pathogen surfaces, dimers of MBL-associated serine proteases 1 and 2 (MASP-1 and MASP-2) activate a proteolytic cascade, which culminates in the formation of the membrane attack complex and pathogen lysis. Alternative splicing of the pre-mRNA encoding MASP-1 results in two other products, MASP-3 and MAp44, which regulate activation of the cascade. A similar mechanism allows the gene encoding MASP-2 to produce the truncated MAp19 protein. Polymorphisms in MASP1 and MASP2 genes are associated with protein serum levels and functional activity. Since the first report of a MASP deficiency in 2003, deficiencies in lectin pathway proteins have been associated with recurrent infections and several polymorphisms were associated with the susceptibility or protection to infectious diseases. In this review, we summarize the findings on the role of MASP polymorphisms and serum levels in bacterial, viral and protozoan infectious diseases.


Subject(s)
Bacterial Infections/immunology , Mannose-Binding Protein-Associated Serine Proteases/immunology , Protozoan Infections/immunology , Virus Diseases/immunology , Bacterial Infections/genetics , Bacterial Infections/microbiology , Bacterial Infections/pathology , Complement Pathway, Mannose-Binding Lectin/genetics , Complement System Proteins/genetics , Complement System Proteins/immunology , Gene Expression Regulation/immunology , Humans , Mannose-Binding Lectin/genetics , Mannose-Binding Lectin/immunology , Mannose-Binding Protein-Associated Serine Proteases/genetics , Polymorphism, Genetic , Protozoan Infections/genetics , Protozoan Infections/parasitology , Protozoan Infections/pathology , Signal Transduction , Virus Diseases/genetics , Virus Diseases/pathology , Virus Diseases/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...